CrossRef Integrative MultiOmics Analysis Elucidates the Progressive Disease Landscape and Reveals Dynamic Protein Biomarkers for MASLD Surveillance Kejun Liu, Bozhi Zhang, Yezhen Tang, Zhenyao Tan, Yang Bu, Yongxue Lv The FASEB Journal .2026;[Epub] CrossRef A novel serum metabolite classifier for identifying Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) integrating metabolomics and machine learning Binghui Li, Yiru Zhang, Ziyang Li, Zhiyang Chen, Zhe Guo, Weimin Wu, Li Tan, Lini Dong, Xiangyu Zhang, Xing Lyu, Min Hu, Qichen Long BMC Gastroenterology .2026;[Epub] CrossRef Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial Lee M
Bejarano I, Dorado-Silva M, Sarmiento-Soto H, et al
Self administration of peptide therapy can create ineffective outcomes or, worse, unintended health risks without oversight
When to Speak to a Professional Supplementing with intention means knowing when to seek expert medical advice
The flat-pricing structure is designed to make ongoing dose adjustments cost-neutral a practical advantage for patients whose clinician titrates their medication over time
